Afuco™ Anti-Human NRP2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-NRP2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-human neuropilin-2(NRP-2) antibodies which recognizes rrNeuropilin-2 extracellular domain can be used for obtaining a medicament intended to increase p53 expression and to induce tumour cell apoptosis in the context of an anticancer treatment.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-703CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | NRP2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |